SSRI fluoxetine inhibits coxsackie

http://www.ncbi.nlm.nih.gov/pubmed/22751539

 

Antimicrob Agents Chemother. 2012 Sep;56(9):4838-44. doi: 10.1128/AAC.00983-12. Epub 2012 Jul 2.

Fluoxetine is a potent inhibitor of coxsackievirus replication.

Zuo J, Quinn KK, Kye S, Cooper P, Damoiseaux R, Krogstad P.

Source

Department of Pediatrics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.

Abstract

No antiviral drugs currently exist for the treatment of enterovirus infections, which are often severe and potentially life threatening. Molecular screening of small molecule libraries identified fluoxetine, a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication. Fluoxetine did not interfere with either viral entry or translation of the viral genome. Instead, fluoxetine and its metabolite norfluoxetine markedly reduced the synthesis of viral RNA and protein. In view of its favorable pharmacokinetics and safety profile, fluoxetine warrants additional study as a potential antiviral agent for enterovirus infections.

PMID:

22751539

[PubMed - in process]

PMCID:

PMC3421851

[Available on 2013/3/1]